Neonatal plasma TSH--estimated upper reference intervals for diagnosis and follow up of congenital hypothyroidism

Carol Evans1, Sarah Neale, John Geen

  • 1Department of Medical Biochemistry and Immunology, University Hospital of Wales, Cardiff, UK. carol.evans@cardiffandvale.wales.nhs.uk

Insights

Accurate plasma thyroid-stimulating hormone (TSH) reference intervals are crucial for diagnosing congenital hypothyroidism. This study establishes new method-dependent plasma TSH reference intervals using newborn screening data, aiding clinical diagnosis.

Area of Science:

  • Endocrinology
  • Paediatric diagnostics
  • Clinical chemistry

Background:

  • Accurate plasma thyroid-stimulating hormone (TSH) reference intervals are vital for diagnosing and managing congenital hypothyroidism in infants.
  • Establishing reliable reference intervals is challenging due to difficulties in obtaining samples from healthy paediatric populations.

Purpose of the Study:

  • To estimate method-dependent plasma TSH upper-reference intervals for paediatric use.
  • To overcome limitations in obtaining healthy paediatric plasma samples for TSH analysis.

Main Methods:

  • Determined the blood spot TSH upper-reference interval from a large newborn screening dataset (N = 10,697).
  • Derived method-dependent conversion factors from paired blood spot and plasma TSH measurements.
  • Calculated plasma TSH upper-reference intervals for five different TSH assay methods.

Main Results:

  • The blood spot TSH upper-reference interval was established at 3.04 mU/L (97.5th centile).
  • Estimated plasma TSH upper-reference intervals varied by assay method, ranging from 6.3 to 8.3 mU/L.
  • Specific upper reference intervals were provided for Siemens Centaur, Abbott Architect, Roche Elecsys E170, Siemens Immulite 2000, and Beckman Access HYPERsensitive TSH assays.

Conclusions:

  • The estimated method-dependent plasma TSH upper reference intervals are practical tools for clinicians.
  • These intervals will assist in diagnosing and monitoring infants with elevated blood spot TSH concentrations identified through newborn screening.

Related Concept Videos

Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Functions of Thyroid Hormones01:18

Functions of Thyroid Hormones

The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...